Wednesday, September 25, 2013
Matahari Department Store (Target price IDR15,000 from IDR 16,000)
Consumer Demand Is Alive And Well
Look out for strong 3Q; Reiterate BUY. Despite macroeconomic uncertainty, we do not see sales slowing at Matahari Department Store (MDS) given product mix and continuing expansion. The upcoming 3Q is seasonally the most important quarter (3Q12 was 36% of FY12 sales), and the company expects to continue generating strong operating leverage in 2H13. As evidence, despite cost pressure from minimum wage hikes, MDS still saw 2Q13 operating profit increase 19% YoY on the back of SSSG coming in strongly at 14.9% YoY.
Delays in mall openings, but growth plan intact. MDS opened five new stores in 1H13 – one each in Greater Jakarta and Sumatra, two in Kalimantan and one in East Indonesia. Management said there might be some slippage in store openings this year due to the delay in mall openings, but remains committed to opening 45 stores during FY13-15. We adjust our assumptions accordingly but believe the scope for new store opening remains strong, with total store count now totaling 70.
Interest savings may contribute to bottomline surprises. MDS has paid off IDR400b in debt as of end-July 2013, in addition to the IDR700b paid in 1Q13. Ytd, these already exceeds our earlier assumption of IDR1t for the full year. We therefore raise our debt repayment forecast for 2013 to IDR1.4t vs the company’s estimate of ~IDR1.5t. The ensuing interest savings result in our FY13F-15F earnings forecasts increasing by 15-18%.
Price advantage over peers. Our latest channel checks reveal that clothing products at Sogo and Uniqlo are priced at a 55-140% premium over MDS’s private labels. In our view, MDS’s private-label brands are a key competitive advantage as they enjoy strong brand recognition and are sold exclusively through MDS stores. This is important as private-label brands made up around 40% of the company’s total net sales.
Reiterate BUY; TP IDR15,000. We switch our methodology to PEG-based TP, from Price-to-Sales, to better capture its strong earnings growth profile and reiterate our BUY with a new TP of IDR15,000, pegged to 0.9x FY14F PEG (regional sector average of 0.9x FY14F). This cross-checks against our DCF derived value of IDR15,400 (see figures 5 and 7 for details) and our former P/S value of IDR16,000. Current valuation at 23.7x FY14F PER looks attractive to us, considering MDS’s dominant market position, robust EPS growth (26.6% CAGR over FY13-FY15F) and strong cash flow generation.
source: KIMENG dated 24 September 2013
Look out for strong 3Q; Reiterate BUY. Despite macroeconomic uncertainty, we do not see sales slowing at Matahari Department Store (MDS) given product mix and continuing expansion. The upcoming 3Q is seasonally the most important quarter (3Q12 was 36% of FY12 sales), and the company expects to continue generating strong operating leverage in 2H13. As evidence, despite cost pressure from minimum wage hikes, MDS still saw 2Q13 operating profit increase 19% YoY on the back of SSSG coming in strongly at 14.9% YoY.
Delays in mall openings, but growth plan intact. MDS opened five new stores in 1H13 – one each in Greater Jakarta and Sumatra, two in Kalimantan and one in East Indonesia. Management said there might be some slippage in store openings this year due to the delay in mall openings, but remains committed to opening 45 stores during FY13-15. We adjust our assumptions accordingly but believe the scope for new store opening remains strong, with total store count now totaling 70.
Interest savings may contribute to bottomline surprises. MDS has paid off IDR400b in debt as of end-July 2013, in addition to the IDR700b paid in 1Q13. Ytd, these already exceeds our earlier assumption of IDR1t for the full year. We therefore raise our debt repayment forecast for 2013 to IDR1.4t vs the company’s estimate of ~IDR1.5t. The ensuing interest savings result in our FY13F-15F earnings forecasts increasing by 15-18%.
Price advantage over peers. Our latest channel checks reveal that clothing products at Sogo and Uniqlo are priced at a 55-140% premium over MDS’s private labels. In our view, MDS’s private-label brands are a key competitive advantage as they enjoy strong brand recognition and are sold exclusively through MDS stores. This is important as private-label brands made up around 40% of the company’s total net sales.
Reiterate BUY; TP IDR15,000. We switch our methodology to PEG-based TP, from Price-to-Sales, to better capture its strong earnings growth profile and reiterate our BUY with a new TP of IDR15,000, pegged to 0.9x FY14F PEG (regional sector average of 0.9x FY14F). This cross-checks against our DCF derived value of IDR15,400 (see figures 5 and 7 for details) and our former P/S value of IDR16,000. Current valuation at 23.7x FY14F PER looks attractive to us, considering MDS’s dominant market position, robust EPS growth (26.6% CAGR over FY13-FY15F) and strong cash flow generation.
source: KIMENG dated 24 September 2013